Befejeződött1. fázis
A Phase 1b, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB310 in Patients with Active, Mild to Moderate Ulcerative Colitis (COMPOSER-1)
Key facts
- Where
- Bydgoszcz, Elblag, Rzeszów és Warsaw, LengyelországSee the 6 sites
- Phase
- 1. fázis
Where in Lengyelország
- Centrum Medyczne Kermed Renata Bijata-Bronisz I Ewa Kowalinska Sp. j.Bydgoszcz, LengyelországNo longer taking part
- Niepubliczny Zaklad Opieki Zdrowotnej Twoje Zdrowie El Sp. z o.o.Elblag, LengyelországNo longer taking part
- Korczowski Bartosz, Gabinet LekarskiRzeszów, LengyelországNo longer taking part
- Medical Network Sp z o oWarsaw, LengyelországNo longer taking part
- Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych i AdministracjiWarsaw, LengyelországNo longer taking part
- Wojskowy Instytut Medyczny Panstwowy Instytut BadawczyWarsaw, LengyelországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Microbiotica Limited
- Trial code
- EU 2023-507376-50-00
- Record updated
- 2025. augusztus 11.